Rhino 69 Extreme 50000 packaged in 1 capsule per blister pack — Class I drug recall D-0821-2018
Terminated recall by AMA Wholesale, reported 2018-05-30, distributed nationwide. Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared tadalafil. The pre
| Recall number | D-0821-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | AMA Wholesale, Chino Hills, CA, United States |
| Recall initiated | 2018-04-12 |
| Classified | 2018-05-18 |
| Reported by FDA | 2018-05-30 |
| Terminated | 2021-04-07 |
| Distributed | Nationwide (US) |
| Reason classes | undeclared allergen, unapproved product |
| UPC / GTIN / UDI-DI | 00718122071128 |
Product
Rhino 69 Extreme 50000 packaged in 1 capsule per blister pack, Distributed by AMA Wholesale Inc. Chino Hills, CA, 91709-2618, UPC Code: 718122071128
Reason for recall
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared tadalafil. The presence of tadalafil makes Rhino Extreme 50000 an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0821-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.